Jane Street Portfolio holdings
Jane Street Group, founded in 2000 by Tim Reynolds, Rob Granieri, Marc Gerstein, and Michael Jenkins, is a New York City-based quantitative trading firm renowned for its technological prowess and collaborative problem-solving culture. Specializing in liquidity provision and market-making, it trades a vast array of financial products—including equities, bonds, options, and ETFs—across over 200 venues in 45 countries, handling trillions in securities annually. The firm, which employs over 2,600 people across offices in New York, London, Hong Kong, Amsterdam, Chicago, and Singapore, leverages advanced algorithms and a nearly 70-million-line OCaml codebase to dominate markets, notably ETFs, where it plays a critical role as an authorized participant. With net trading revenues exceeding $10 billion annually in recent years, including a record $10.6 billion in 2023, Jane Street has emerged as a secretive yet powerful force in global finance, outpacing traditional Wall Street giants like Goldman Sachs in trading profitability.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$2.07B |
| 2 |
Apple
AAPL
|
+$1B |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$994M |
| 4 |
CRWV
CoreWeave
CRWV
|
+$858M |
| 5 |
Broadcom
AVGO
|
+$665M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Dell
DELL
|
+$851M |
| 2 |
iShares Bitcoin Trust
IBIT
|
+$700M |
| 3 |
Columbia Research Enhanced Core ETF
RECS
|
+$640M |
| 4 |
Nasdaq
NDAQ
|
+$561M |
| 5 |
T-Mobile US
TMUS
|
+$542M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.36% |
| 2 | Consumer Discretionary | 1.3% |
| 3 | Financials | 1.2% |
| 4 | Healthcare | 1.11% |
| 5 | Industrials | 0.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SOL
10251
DELISTED
Emeren Group
SOL
| $51.9K | ﹤0.01% |
27,480
-68,461
| -71% | -$129K |
|
10252
PUT
KULR Technology Group
KULR
$122M
| $51.9K | ﹤0.01% |
+12,484
| New | +$66.5K |
|
10253
CALL
Gran Tierra Energy
GTE
$325M
| $51.8K | ﹤0.01% |
+11,900
| New | +$50.4K |
|
|
SRTA
10254
PUT
Strata Critical Medical Inc
SRTA
$522M
| $51.6K | ﹤0.01% |
10,200
+100
| +1% | +$442 |
|
10255
CALL
VistaGen Therapeutics
VTGN
$11.9M
| $51.5K | ﹤0.01% |
+14,500
| New | +$43.3K |
|
|
HERZ
10256
Herzfeld Credit Income Fund
HERZ
$32.6M
| $51.4K | ﹤0.01% |
+2,161
| New | +$52.8K |
|
10257
BARK
BARK
$91.4M
| $51.4K | ﹤0.01% |
3,091
-15,013
| -83% | -$265K |
|
10258
PUT
Funko
FNKO
$344M
| $51.3K | ﹤0.01% |
+14,900
| New | +$55.3K |
|
10259
CALL
Apyx Medical
APYX
$128M
| $50.5K | ﹤0.01% |
+23,600
| New | +$50K |
|
10260
Wrap Technologies
WRAP
$105M
| $50.4K | ﹤0.01% |
23,237
-224
| -1% | -$361 |
|
10261
PUT
Microbot Medical
MBOT
$104M
| $50.3K | ﹤0.01% |
+16,500
| New | +$51.5K |
|
10262
CALL
Biomea Fusion
BMEA
$95.7M
| $50.3K | ﹤0.01% |
24,900
+8,700
| +54% | +$15.9K |
|
10263
Prelude Therapeutics
PRLD
$443M
| $50.1K | ﹤0.01% |
34,822
-56,931
| -62% | -$57.1K |
|
10264
Skye Bioscience
SKYE
$17.6M
| $50.1K | ﹤0.01% |
+12,737
| New | +$48.1K |
|
|
AIFC
10265
CALL
AI Financial Corp
AIFC
$57M
| $49.5K | ﹤0.01% |
+18,400
| New | +$110K |
|
10266
PUT
Polestar Automotive Holding UK
PSNY
$2.06B
| $49.4K | ﹤0.01% |
1,750
-33
| -2% | -$1.06K |
|
10267
HeartCore Enterprises
HTCR
$3.75M
| $49.4K | ﹤0.01% |
+3,048
| New | +$42.2K |
|
|
YARW
10268
Yarrow Bioscience
YARW
$113M
| $49.3K | ﹤0.01% |
2,942
+446
| +18% | +$14.6K |
|
|
MTVA
10269
MetaVia Inc
MTVA
$7.69M
| $48.8K | ﹤0.01% |
+4,714
| New | +$38.1K |
|
10270
CALL
Kopin
KOPN
$1.02B
| $48.6K | ﹤0.01% |
20,000
-43,700
| -69% | -$89.2K |
|
10271
PUT
FTAI Infrastructure
FIP
$533M
| $48.4K | ﹤0.01% |
11,100
-102,900
| -90% | -$557K |
|
|
SONN
10272
DELISTED
Sonnet BioTherapeutics
SONN
| $48.4K | ﹤0.01% |
+10,562
| New | +$46.8K |
|
10273
CALL
Neumora Therapeutics
NMRA
$301M
| $48.2K | ﹤0.01% |
26,500
+6,000
| +29% | +$9.7K |
|
10274
PUT
Zura Bio
ZURA
$534M
| $48.1K | ﹤0.01% |
+11,100
| New | +$20K |
|
|
WHWK
10275
Whitehawk Therapeutics
WHWK
$254M
| $47.9K | ﹤0.01% |
25,215
-80,095
| -76% | -$147K |
|
Similar funds
Jane Street's Q3 2025 Portfolio in Review
As of Q3 2025, Jane Street held 12,194 positions worth $657B, up 30% from $506B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
Jane Street deployed $82.2B of net new capital in Q3 2025, opening 2,712 new positions and adding to 4,395 existing holdings. Its largest new stake was iShares MSCI Emerging Markets ex China ETF: 3,719,407 shares worth $251M.
By sector, the portfolio is most concentrated in Technology at 3.4% of assets, up from 2.3% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was Dell, an estimated $851M trimmed.
- Jane Street's largest Q3 2025 buy was iShares MSCI Emerging Markets ex China ETF: 3,719,407 shares worth $251M.
- Jane Street added most to NVIDIA in Q3 2025, an estimated $2.07B increase.
- Jane Street's biggest Q3 2025 reduction was Dell, cutting an estimated $851M.
- Jane Street fully exited iShares Core US Aggregate Bond ETF in Q3 2025, selling an estimated $441M.
- Jane Street's ten largest holdings make up 36% of its $657B portfolio in Q3 2025.
- Jane Street opened 2,712 new positions and closed 1,541 in Q3 2025.
- Jane Street's portfolio value rose 30% quarter-over-quarter to $657B.
Based on Jane Street's 13F filing for Q3 2025, filed 14 Nov 2025.